SYDNEY NEWTON: Open Payments
NPI 1912383480 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 108 payments from 17 companies in 2025. Trend: 2023 $1,190 · 2024 $749 · 2025 $2,046
Food & beverage: $1,813Education: $233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $399 |
| Novartis Pharmaceuticals Corporation | 16 | $355 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $197 |
| LEO Pharma Inc. | 13 | $194 |
| E.R. Squibb & Sons, L.L.C. | 8 | $178 |
| GENZYME CORPORATION | 12 | $164 |
| Janssen Biotech, Inc. | 2 | $83 |
| Amgen Inc. | 4 | $83 |
| Almirall LLC | 2 | $79 |
| PFIZER INC. | 4 | $75 |
Products named: SKYRIZI, Sotyktu, COSENTYX, DUPIXENT, ADBRY, ILUMYA, TREMFYA, OTEZLA.
Industry payments across KY — which companies pay providers there.
